Horizon Pharma proposes to buy Depomed for $1.75 billion
July 07, 2015 at 08:11 AM EDT
Ireland-based Horizon Pharma proposed to buy Depomed for $1.75 billion, but Depomed has rejected the deal.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.